Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History

@article{Grandi2018CombinedHC,
  title={Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History},
  author={G. Grandi and A. Toss and A. Cagnacci and L. Marcheselli and Silvia Pavesi and F. Facchinetti and S. Cascinu and L. Cortesi},
  journal={Clinical Breast Cancer},
  year={2018},
  volume={18},
  pages={e15–e24}
}
Micro‐Abstract CHCs are the most used methods of contraception in the more developed world. Their use does not increase the risk of breast cancer in women with a family history of BC from our Family Cancer Clinic. These results are confirmed for very‐high‐risk (BRCA1‐2), high‐risk and intermediate‐risk groups. Background: We estimated the association between combined hormonal contraceptive (CHC) use and breast cancer (BC) incidence in a well‐selected population of women at familial risk of BC… Expand
Health outcomes associated with use of hormonal contraception: breast cancer
Hormonal contraceptives and breast cancer: Clinical data.
Combined hormonal contraceptives in BRCA gene mutation carriers: why not?
A framework for personalized mammogram screening
Female Reproductive Dysfunction

References

SHOWING 1-10 OF 35 REFERENCES
Hormonal contraception and risk of cancer.
Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group.
  • R. Brohet, D. Goldgar, +16 authors M. Rookus
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2007
Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.
Oral contraceptives and the risk of breast cancer
...
1
2
3
4
...